Trial
NCT03365661
QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
University of Minnesota
Condition
High-Risk Acute Myeloid Leukemia
Intervention
ALT-803
Why stopped
Sponsor halted study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-09